Cargando…
A Promising Small Molecule for Vanishing White Matter Disease
Investigators from Calico Life Sciences LLC and AbbVie report the effects of a novel drug targeting the genetic basis of Vanishing White Matter Disease (VWMD).
Autores principales: | Mithal, Divakar S., Rubin, Jennifer P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pediatric Neurology Briefs Publishers
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6115330/ https://www.ncbi.nlm.nih.gov/pubmed/30174381 http://dx.doi.org/10.15844/pedneurbriefs-32-5 |
Ejemplares similares
-
Axonal abnormalities in vanishing white matter
por: Klok, Melanie D., et al.
Publicado: (2018) -
Regional vulnerability of brain white matter in vanishing white matter
por: Man, Jodie H.K., et al.
Publicado: (2023) -
Natural History of Vanishing White Matter
por: Hamilton, Eline M. C., et al.
Publicado: (2018) -
Diabetic ketoacidosis in vanishing white matter
por: Alamri, Hannadi, et al.
Publicado: (2016) -
Cortical Pathology in Vanishing White Matter
por: Man, Jodie H. K., et al.
Publicado: (2022)